Without challenge, there is no change – the move to precision medicine
Posted 5th September 2018 by Jane Williams
I don’t need to tell you that pharma has changed, that it is still changing at speed, or that change is the new normal. I don’t need to tell you because you − more than anyone else − already know. The passing of the blockbuster era has caused uncertainty. Without the superstar drugs of old, where does the industry go next? It’s a serious challenge, but without challenge, there is no change. The answer, of course, is the scalar shift from blockbuster generic to precision medicine specific.
The Future of AI: A Q&A with Brandon Allgood
Posted 3rd September 2018 by Jane Williams
Brandon Allgood is the Chief Technology Officer at Numerate, as well as a co-founder. In addition to being responsible for the development of Numerate’s cloud-based machine learning platforms, Brandon runs the software & data science teams, and is the technical lead on all of the companies internal drug programs, as well as external collaborations.
Here, Brandon talks about what he thinks the future holds for AI and machine learning:
Accelerating the Medicinal Chemistry Design Cycle
Posted 6th April 2018 by Jane Williams
MedChemNet and Future Medicinal Chemistry editors Jasmine Harris and Ben Walden interviewed Emma Parmee from Merck & Co at the Global Medicinal Chemistry and GPCR Summit.
Medical Device Cyber Security: An Open Letter From Jim Jacobson
Posted 28th March 2018 by Jane Williams
Dear Colleagues,
The time for comprehensive IT security within healthcare facilities has come. We see news stories every day making the need obvious: stolen data, compromised devices, and interruptions in care delivery. The cyber security threat landscape is constantly evolving. Our defensive measures must evolve too.
Optimising Targeted Protein Degradation
Posted 26th March 2018 by Jane Williams
02MedChemNet and Future Medicinal Chemistry editors Jasmine Harris and Ben Walden interviewed George Burslem from Yale University at the Global Medicinal Chemistry and GPCR Summit.
Insights in Medicinal Chemistry and GPCR
Posted 23rd February 2018 by Jane Williams
MedChemNet and Future Medicinal Chemistry editors Jasmine Harris and Ben Walden share 5 key insights gained from the Global Medicinal Chemistry and GPCR Summit.
Cyber Security Challenges in the Pharma Industry
Posted 19th February 2018 by Jane Williams
In general, the pharma industry has not been cutting-edge in terms of maturity in information security practices.
The Microbiome Represents a Paradigm Shift for European Pharmaceutical Regulators
Posted 16th February 2018 by Jane Williams
Recent microbiome research has demonstrated the important role that these communities of microorganisms play on human homeostasis. The gut microbiome is being thoroughly studied, and other microbiomes are now becoming the focus of greater attention, as well as other organs of the host, due to the concept of ‘axes,’ such as the gut-brain axis, gut-lung axis, gut-liver axis.